Background. Human African trypanosomiasis (HAT) caused by Trypanosoma brucei gambiense can be diagnosed in the early hemolymphatic stage (stage 1 [S1]) or meningoencephalitic stage (stage 2 [S2]).

Chad has eliminated human African trypanosomiasis, a fly-borne tropical disease also known as sleeping sickness, the World Health Organization recently announced. The elimination marks a milestone for ...

The World Health Organization (WHO) congratulates Guinea for eliminating the gambiense form of human African trypanosomiasis as a public health problem. This form of human African trypanosomiasis, the ...

Trypanosomatids are parasites that can result in more than 1 billion potentially fatal infections per year globally. In Africa, Human African Trypanosomiasis (HAT), better known as sleeping sickness, ...

A single dose of oral acoziborole proved to be efficacious and safe for adults and adolescents with gambiense human African trypanosomiasis (HAT), also known as "sleeping sickness," suggesting its ...

A multi-center, open-level, phase II/III clinical trial has recently been conducted to evaluate the efficacy and safety of the oral antimicrobial drug acoziborole in patients with human African ...

A single dose of oral acoziborole resulted in a greater than 95% cure or probable cure rate for human African trypanosomiasis (HAT), also known as sleeping sickness, according to results from a ...

A herdsman sprays cattle with insecticide to prevent tsetse fly infestation during the Kenya Tsetse and Trypanosomiasis Eradication Council visit to tsetse fly-prone areas in Kina, Isiolo county.